Enwei Pharmaceutical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Net Income	48.14	51.94	37.5	86.31	67.8	101.73
Depreciation & Amortization	47.82	47.82	46.13	34.83	30.91	30.5
Other Amortization	4.47	4.47	6.58	6.55	6.88	5.59
Loss (Gain) From Sale of Assets	0.14	0.14	0.26	0.04	-	-
Asset Writedown & Restructuring Costs	2.54	2.54	5.44	0.58	1.65	0.07
Loss (Gain) From Sale of Investments	-5.2	-5.2	-3.49	-3.74	-0.59	0.44
Other Operating Activities	-23.17	1.2	23.84	0.35	-1.56	-0.52
Change in Accounts Receivable	-21.12	-21.12	-36.43	-9.67	-69.89	30.16
Change in Inventory	16.43	16.43	-12.06	-2.9	5.4	-31.39
Change in Accounts Payable	3.16	3.16	12.96	-27.81	22.12	-50.73
Change in Other Net Operating Assets	6.78	6.78	-	-	-	-
Operating Cash Flow	81.42	109.59	78.92	84.01	62.35	87.58
Operating Cash Flow Growth	-16.52%	38.87%	-6.06%	34.73%	-28.80%	11.53%
Capital Expenditures	-56.85	-56.38	-50.23	-134.05	-23.56	-38.21
Sale of Property, Plant & Equipment	0.04	0.04	0.34	0.15	-	-
Cash Acquisitions	-0.07	-0.07	-	-	-	-
Investment in Securities	-19.18	-19.18	-1,018	-685.5	-221.5	-
Other Investing Activities	-4.49	-3.24	957.37	775.22	1.05	0.52
Investing Cash Flow	-80.55	-78.83	-110.62	-44.18	-244.01	-37.7
Long-Term Debt Issued	-	-	241.8	-	-	-
Long-Term Debt Repaid	-	-10	-48.09	-	-	-
Net Debt Issued (Repaid)	-10	-10	193.71	-	-	-
Issuance of Common Stock	10.77	10.77	18.36	-	470.75	-
Repurchase of Common Stock	-	-	-70.01	-33	-	-
Common Dividends Paid	-56.17	-20.78	-56.96	-112.22	-	-46
Other Financing Activities	-1.85	-1.69	-	-	-12.28	-2.41
Financing Cash Flow	-57.25	-21.69	85.1	-145.22	458.47	-48.41
Foreign Exchange Rate Adjustments	-0	-0	0	-0.03	0.16	-0.24
Net Cash Flow	-56.38	9.08	53.41	-105.41	276.98	1.23
Free Cash Flow	24.57	53.21	28.69	-50.04	38.8	49.36
Free Cash Flow Growth	-52.07%	85.50%	-	-	-21.41%	4.24%
Free Cash Flow Margin	2.79%	5.91%	3.53%	-6.37%	5.61%	7.26%
Free Cash Flow Per Share	0.24	0.52	0.28	-0.49	0.46	0.63
Cash Income Tax Paid	78.13	76.36	80.87	84.86	58.93	79.2
Levered Free Cash Flow	8.6	70.61	27.34	-68.83	41.25	21.46
Unlevered Free Cash Flow	8.6	70.61	28.85	-68.83	41.25	21.46
Change in Working Capital	6.68	6.68	-37.33	-40.9	-42.73	-50.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.